Related references
Note: Only part of the references are listed.An open label, pilot, randomized controlled trial of noradrenaline Versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response
Praveen Sharma et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relationship between activation of the sympathetic nervous system and renal blood flow autoregulation in cirrhosis
Vanessa P. Stadlbauer et al.
GASTROENTEROLOGY (2008)
Vasoconstrictor therapy for the hepatorenal syndrome
Joseph K. Lim et al.
GASTROENTEROLOGY (2008)
Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome:: A randomized study
Marta Martin-Llahi et al.
GASTROENTEROLOGY (2008)
A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome
Arun J. Sanyal et al.
GASTROENTEROLOGY (2008)
Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis
Paolo Angeli et al.
JOURNAL OF HEPATOLOGY (2008)
Outcome predictors and new score of critically ill cirrhotic patients with acute renal failure
Ji-Tseng Fang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
The hepatorenal syndrome
Santiago J. Munoz
MEDICAL CLINICS OF NORTH AMERICA (2008)
Prediction of survival after liver transplantation by pre-transplant parameters
Tobias J. Weismueller et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Pathogenesis and treatment of hepatorenal syndrome
Vicente Arroyo et al.
SEMINARS IN LIVER DISEASE (2008)
Bacterial infections, sepsis, and multiorgan failure in cirrhosis
Puneeta Tandon et al.
SEMINARS IN LIVER DISEASE (2008)
Extent of bilirubin interference with Beckman creatinine methods
Goce Dimeski et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2008)
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome
Sergio Neri et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome
Aleksander Krag et al.
HEPATOLOGY (2007)
Acute renal dysfunction in liver diseases
Alex P. Betrosian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: A prospective, randomized, unblinded, pilot study
C. Alessandria et al.
JOURNAL OF HEPATOLOGY (2007)
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements
E. Cholongitas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis
Javier Fernandez et al.
GASTROENTEROLOGY (2007)
Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome
Eric Esrailian et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Intravenous albumin is not necessary in cirrhotic patients with spontaneous bacterial peritonitis and low-risk of mortality
M. Casas et al.
JOURNAL OF HEPATOLOGY (2007)
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta et al.
CRITICAL CARE (2007)
Diagnosis and treatment of acute renal failure in patients with cirrhosis
Richard Moreau et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2007)
Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US:: Where will MELD lead us?
T. A. Gonwa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation
Brendan M. McGuire et al.
ANNALS OF INTERNAL MEDICINE (2006)
The hyperdynamic circulation of chronic liver diseases: From the patient to the molecule
Y Iwakiri et al.
HEPATOLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis:: Value of MELD score
C Terra et al.
GASTROENTEROLOGY (2005)
Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure:: A prospective pilot study
JM Péron et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis
D du Cheyron et al.
INTENSIVE CARE MEDICINE (2005)
Impact of pretransplant renal failure: When is listing for kidney-liver indicated?
CL Davis
LIVER TRANSPLANTATION (2005)
Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study
TH Kiser et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Circulatory function and hepatorenal syndrome in cirrhosis
L Ruiz-del-Arbol et al.
HEPATOLOGY (2005)
MELD score and clinical type predict prognosis in hepatorenal syndrome:: Relevance to liver transplantation
C Alessandria et al.
HEPATOLOGY (2005)
Urinary interleukin-18 is a marker of human acute tubular necrosis
CR Parikh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations
T Gonwa et al.
LIVER TRANSPLANTATION (2004)
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome
F Wong et al.
HEPATOLOGY (2004)
Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study
T Restuccia et al.
JOURNAL OF HEPATOLOGY (2004)
Octreotide in hepatorenal syndrome: A randomized, double-blind, placebo-controlled, crossover study
G Pomier-Layrargues et al.
HEPATOLOGY (2003)
Beneficial effects of terlipressin in hepatorenal syndrome: A prospective, randomized placebo-controlled clinical trial
P Solanki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Model for End-Stage Liver Disease (MELD) and allocation of donor livers
R Wiesner et al.
GASTROENTEROLOGY (2003)
Terlipressin therapy with and without albumin for patients with Hepatorenal syndrome:: Results of a prospective, nonrandomized study
R Ortega et al.
HEPATOLOGY (2002)
Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome:: A pilot study
C Duvoux et al.
HEPATOLOGY (2002)
Clinical course, predictive factors and prognosis in patients with cirrhosis and type 1 hepatorenal syndrome treated with Terlipressin:: A retrospective analysis
I Colle et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation
S Nair et al.
HEPATOLOGY (2002)
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome:: A retrospective multicenter study
R Moreau et al.
GASTROENTEROLOGY (2002)
Molecular and structural consequences of early renal allograft injury
K Baboolal et al.
KIDNEY INTERNATIONAL (2002)
Effect of terlipressin (Glypressin®) on hepatorenal syndrome in cirrhotic patients:: results of a multicentre pilot study
C Halimi et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2002)
Octreotide potentiates PKC-dependent vasoconstrictors in portal-hypertensive and control rats
R Wiest et al.
GASTROENTEROLOGY (2001)
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study
KA Brensing et al.
GUT (2000)
Terlipressin plus albumin infusion:: an effective and safe therapy of hepatorenal syndrome
J Uriz et al.
JOURNAL OF HEPATOLOGY (2000)
Transjugular intrahepatic portosystemic shunt for cirrhosis and ascites:: Effects in patients with organic or functional renal failure
P Michl et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2000)
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS:: Results of a prospective, randomized, controlled clinical trial
SR Mitzner et al.
LIVER TRANSPLANTATION (2000)
Share Paper
